NCT03735771View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine

0.25% bupivacaine plus fentanyl 8 mcg/ml

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03735771 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 2.5ml of Bupivacaine 0.25% Plus Fentanyl 8 mcg/ml | Biotech Hunter | Biotech Hunter